Validation of an Allergic Rhinitis Control Test in Children
- Conditions
- Allergic Rhinitis
- Registration Number
- NCT03075917
- Lead Sponsor
- University Hospital, Montpellier
- Brief Summary
Allergic rhinitis is a common condition that affects adults as well as children and adolescents, often with impaired quality of life. Patients often report a poor level of satisfaction with the effectiveness of their treatment and are always looking for more drug combinations to improve their symptom. Several tools exist for assessing control of allergic rhinitis, but none has been validated in teenagers or in children. A study conducted in 2008, resulted in the validation of a self-administered control test of allergic rhinitis (ARCT) in patients from 12 years of age. We propose to adapt ARCT adult to pediatric population from 5 to 11 years old.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 135
- Patients aged 5 to 11 years old, consulting a practitioner for an allergic rhinitis
- Parents formulated their study participation agreement by signing the consent form.
- Patients that are already treated for the actual episode of allergic rhinitis and are satisfied of the treatment.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Score of the allergic rhinitis control self questionnaire 15 days Score of the allergic rhinitis control self questionnaire in teenagers from 5 to 11 years old.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (6)
CH Louis Pasteur
🇫🇷Bagnols-sur-Cèze, France
Maison de santé de Lasalle
🇫🇷Lasalle, France
CH de MILLAU
🇫🇷Millau, France
Centre (Ctre) Medical Ravas - Malbosc
🇫🇷Montpellier, France
University hospital of Montpellier
🇫🇷Montpellier, France
Hôpital Trousseau,
🇫🇷Paris, France
CH Louis Pasteur🇫🇷Bagnols-sur-Cèze, France